Brand Comparison
SkinMedica vs Rejuran
A head-to-head comparison of two popular K-beauty brands. Which one is right for your skin?
Our Pick
SkinMedica
Higher editor rating (9 vs 8.7)
SkinMedica
SkinMedica is the US physician-dispensed brand responsible for mainstreaming growth-factor serums. The TNS Advanced+ Serum — derived from human fibroblast growth factors — is the most-prescribed post-procedure recovery serum in US cosmetic dermatology for a reason. Clinical-grade, eye-watering pricing, genuinely-documented efficacy for photoaged skin. Not for everyone — but for the "I'm four weeks post-Fraxel and need recovery" use case, nothing beats it.
Pros
- ✓ growth-factor technology with real published data
- ✓ TNS Advanced+ is the US post-procedure gold standard
- ✓ Allergan-owned — serious regulatory discipline
- ✓ physician-channel gatekeeping means fewer counterfeits
Cons
- ✗ premium pricing ($295+ for flagship serum)
- ✗ growth-factor sourcing raises ethical questions for some buyers (human fibroblast-derived)
- ✗ pregnancy-safety debated — most OBGYNs advise against
- ✗ distribution is tightly physician-channel-only
Rejuran
Rejuran is the consumer-skincare arm of Pharma Research Products, the Korean biopharma company that developed the original Rejuran Healer injectable — the same PDRN (polydeoxyribonucleotide) dermal treatment that's been a staple of Korean aesthetic clinics since 2014. The topical line translates that clinical DNA into daily-use products, anchored by the patented c-PDRN® complex at 0.5% concentration plus proprietary DOT® (Dermal Optimizing Technology) delivery. The Turnover Ampoule is the hero: a lightweight serum that targets fine lines, firmness, and texture with the same salmon-DNA active that made the injectable famous. Rejuran launched at Sephora US in 2024, won the 2025 Olive Young Slow Aging award, and has become the face of the PDRN trend that's dominating K-beauty in 2025–2026. The price point is premium-mid ($45–55), justified by the clinical pedigree and patented delivery system. Worth reaching for if you want the PDRN trend from the company that actually invented it.
